Interventional Cardiology

Science News

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions
Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation
Evidence-Based Practices in the Cardiac Catheterization Laboratory
Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction
Mechanical Complications of Acute Myocardial Infarction

Journals

Association Between Radial Versus Femoral Access for Percutaneous Coronary Intervention and Long‐Term Mortality
Effect of Heart Failure on Long‐Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease
Intracranial Bleeding After Percutaneous Coronary Intervention: Time‐Dependent Incidence, Predictors, and Impact on Mortality
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction: Insights From the COMPLETE Trial
Cirrhosis in a 42 Year Old With a History of Attempted Atrial Septal Defect Closure in Childhood

Continuing Education

Doctor looking into a microscope

Meet with us for compelling content and renewed connections at AHA Scientific Sessions 2021. In-person Event in Boston, Massachusetts + Virtual Experience, Saturday, November 13-15.

Abstract presentations are a key component of AHA Scientific Sessions. Abstract presenters have the option to present in person in Boston or as a part of the virtual experience.

The incentive to disseminate the latest cardiovascular and stroke science to colleagues around the world has never been greater.

Clinicians and Scientists thrive on collaboration and sharing their study findings. Present your innovative research to a global audience at Scientific Sessions, the world's premier cardiovascular conference.

We know your work is vital to saving lives. Share it with fellow researchers, clinicians, and scientists.

The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council members work to provide outstanding research, education, outreach, and mentorship opportunities.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.


TAVR Low Risk Bicuspid Study | Basel Ramlawi, MD

Co-Principal Investigator Basel Ramlawi, MD summarizes the results of the TAVR Low Risk Bicuspid Study which he presented virtually for ACC 2020. The prospective single-arm interventional study examined TAVR for patients with severe aortic stenosis. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses